Evantra Life Sciences Private Limited
About Evantra Life Sciences Private Limited
Data last updated:
Evantra Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 17 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24303TG2018PTC129082. Its GSTIN is 37AAFCE3014Q1ZF (Andhra Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rukmini Tikka and Babu Venkata Satya Vijaya Kumar Tikka.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F.No 501 Apuroopa Colony Pragathi Nagar Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2024, the company reported a revenue of ₹23.02 Lakh, a decline of 21% compared to the previous year. For the same year it recorded a net loss of ₹4.78 Lakh (net margin -20.8%) and EBITDA of -₹4.57 Lakh (EBITDA margin -19.9%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years.
Company details
Contact details
Evantra Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressF.No 501 Apuroopa Colony Pragathi Nagar Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
To see the full contact details of Evantra Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Evantra Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Evantra Life Sciences Private Limited, buy the company report.
Financials of Evantra Life Sciences Private Limited
FY 2025 filings availableEvantra Life Sciences Private Limited reported revenue of ₹23.02 Lakh (down 21% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 21% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 10%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.57 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.78 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -19.9% | ||||
| Net Profit Margin | -20.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Evantra Life Sciences Private Limited, buy the company report.
Board of directors of Evantra Life Sciences Private Limited
Evantra Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rukmini Tikka | Director | 17 Dec 2018 | 7 Years 10 Months | Current |
| Babu Venkata Satya Vijaya Kumar Tikka | Director | 17 Dec 2018 | 7 Years 10 Months | Current |
Peer comparison
Evantra Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Runyon Healthcare India Private Limited | ₹23.03 Lakh (FY 2024) | -33.0% | Delhi, India | |||
| Negapatam Industrial Trading Limited | ₹23.03 Lakh (FY 2024) | -71.0% | Chennai, Tamil Nadu, India | |||
| Nucidem Lifesciences Private Limited | ₹23.02 Lakh (FY 2024) | -52.0% | New Delhi, Delhi, India | |||
| Narron Rn333 Healthcare Private Limited | ₹23.02 Lakh (FY 2025) | -21.0% | Surat, Gujarat, India | |||
| Mithra Hybrid Seeds Private Limited | ₹23.02 Lakh (FY 2016) | 101.0% | Hyderabad, Telangana, India | |||
| Evantra Life Sciences Private Limitedthis company | ₹23.02 Lakh (FY 2024) | -₹4.78 Lakh | -20.8% | -21.0% | Hyderabad, Telangana, India | |
| Mokhyam Solution & Services Private Limited | ₹23.01 Lakh (FY 2023) | 296.0% | Alwar, Rajasthan, India | |||
| Albatross Healthcare Private Limited | ₹23.01 Lakh (FY 2024) | 55.0% | Patna, Bihar, India | |||
| Shnaya Industries Private Limited | ₹23.01 Lakh (FY 2025) | -97.0% | Delhi, India | |||
| Argor Pharmaceuticals Private Limited | ₹23 Lakh (FY 2024) | 73.0% | Chennai, Tamil Nadu, India | |||
| Ayodhya Tradelink Private Limited | ₹23 Lakh (FY 2019) | Jodhpur, Rajasthan, India |
To see the full peer comparison of Evantra Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Evantra Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Evantra Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Evantra Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAFCE3014Q1ZF | Andhra Pradesh | Active | 22 Jan 2019 |
To see the full GST registrations and return filing status of Evantra Life Sciences Private Limited, buy the company report.
Recent activity
Evantra Life Sciences Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Babu Venkata Satya Vijaya Kumar Tikka was appointed as Director on 17 Dec 2018.
Frequently asked questions
Evantra Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 17 December 2018 (8+ years old) and is registered under CIN U24303TG2018PTC129082.
Evantra Life Sciences has 2 current directors:
- Rukmini Tikka - Director
- Babu Venkata Satya Vijaya Kumar Tikka - Director
The latest financial statements of Evantra Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Evantra Life Sciences is 37AAFCE3014Q1ZF, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Evantra Life Sciences is U24303TG2018PTC129082. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Evantra Life Sciences was incorporated on 17 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Evantra Life Sciences by revenue are Runyon Healthcare India Private Limited, Negapatam Industrial Trading Limited, Nucidem Lifesciences Private Limited, Narron Rn333 Healthcare Private Limited, Mithra Hybrid Seeds Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Babu Venkata Satya Vijaya Kumar Tikka was appointed as Director on 17 Dec 2018. Rukmini Tikka was appointed as Director on 17 Dec 2018.
The registered office of Evantra Life Sciences is at F.No 501 Apuroopa Colony Pragathi Nagar Kukatpally, Hyderabad, Telangana, India – 500072.
Evantra Life Sciences operates in the food and beverages industry, in the artificial fibres segment.
Evantra Life Sciences can be reached at its registered office: F.No 501 Apuroopa Colony Pragathi Nagar Kukatpally, Hyderabad, Telangana, India – 500072.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
